Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vaccines for tuberculosis: novel concepts and recent progress.

T Mark Doherty1, Peter Andersen

  • 1Department of Infectious Disease Immunology, Statens Serum Institute, Copenhagen, Denmark. TMD@ssi.dk

Clinical Microbiology Reviews
|October 15, 2005
PubMed
Summary

New tuberculosis vaccines are in clinical trials, offering hope beyond the 75-year-old Mycobacterium bovis BCG vaccine. Advances in genomics and immunology are driving the development of improved tuberculosis vaccines.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiplexed targeted mRNA profiling of alcohol-related liver disease reveals stage-specific dysregulation of signaling pathways.

Molecular biology reports·2026
Same author

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study.

The lancet. Gastroenterology & hepatology·2026
Same author

Paired Liver Biopsies vs Noninvasive Tests as Surrogate Endpoints for Clinical Trials in Metabolic and Alcohol-Related Liver Disease and Alcohol-Related Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Reliability of Hepatic Steatosis Quantification by Controlled Attenuation Parameter in Steatotic Liver Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Prevalence of liver fibrosis in the general population (the LiverScreen project): a multinational European cohort study.

Lancet (London, England)·2026
Same author

Fibrosis activity <i>vs</i>. disease stage: Complementary and independent predictors of outcomes in alcohol-related liver disease.

JHEP reports : innovation in hepatology·2026

Area of Science:

  • Immunology
  • Vaccinology
  • Microbiology

Background:

  • The current tuberculosis vaccine, Mycobacterium bovis BCG (bacille Calmette-Guerin), has been used for over 75 years.
  • BCG provides only partial protection against tuberculosis, necessitating the development of new vaccines.
  • Understanding Mycobacterium tuberculosis's immune evasion strategies is crucial for improving vaccination.

Purpose of the Study:

  • To review the immunology of tuberculosis and BCG's limitations.
  • To describe novel tuberculosis vaccine candidates in clinical trials.
  • To outline strategies for stimulating effective immunity against M. tuberculosis.

Main Methods:

  • Review of current scientific literature on tuberculosis immunology and vaccinology.
  • Analysis of advances in proteomics and genomics for vaccine development.

Related Experiment Videos

  • Description of novel vaccine approaches and their immunological targets.

    • Main Results:

    • Significant progress in understanding host-pathogen interactions in tuberculosis.
    • Development of new vaccine candidates utilizing genomic and proteomic insights.
    • Identification of diverse strategies to enhance immune responses against M. tuberculosis.

    Conclusions:

    • New tuberculosis vaccines are emerging from clinical trials, driven by immunological and technological advances.
    • These next-generation vaccines aim to overcome the limitations of BCG.
    • Future vaccination strategies will focus on eliciting more robust and targeted immune responses.